397 related articles for article (PubMed ID: 24640797)
1. Importance of measuring non-HDL cholesterol in type 2 diabetes patients.
Ram N; Ahmed B; Hashmi F; Jabbar A
J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797
[TBL] [Abstract][Full Text] [Related]
2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
5. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
Nichols GA; Vupputuri S; Rosales AG
Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
Cromwell WC; Otvos JD
Am J Cardiol; 2006 Dec; 98(12):1599-602. PubMed ID: 17145217
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
[TBL] [Abstract][Full Text] [Related]
10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
11. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
13. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
14. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.
Modi KD; Chandwani R; Ahmed I; Kumar KV
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S99-S102. PubMed ID: 26589777
[TBL] [Abstract][Full Text] [Related]
15. Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation.
Whiteside W; Tan M; Yu S; Rocchini A
J Pediatr; 2013 Jun; 162(6):1199-204. PubMed ID: 23312682
[TBL] [Abstract][Full Text] [Related]
16. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
Ozder A
Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
19. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
20. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
Rajmohan L; Deepa R; Mohan A; Mohan V
Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
